Algert Global’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-37,341
Closed -$4.58M 1229
2025
Q4
$4.58M Buy
37,341
+4,637
+14% +$564K 0.07% 470
2025
Q3
$3.63M Sell
32,704
-1,825
-5% -$207K 0.06% 500
2025
Q2
$3.83M Buy
34,529
+312
+0.9% +$33.2K 0.08% 417
2025
Q1
$3.83M Sell
34,217
-574
-2% -$59.2K 0.09% 362
2024
Q4
$3.21M Buy
+34,791
New +$3.13M 0.08% 439
2024
Q3
Sell
-3,701
Closed -$254K 1333
2024
Q2
$254K Buy
+3,701
New +$247K 0.01% 1188
2022
Q4
Sell
-9,718
Closed -$600K 1179
2022
Q3
$600K Sell
9,718
-107
-1% -$6.75K 0.04% 746
2022
Q2
$607K Buy
+9,825
New +$608K 0.05% 688
2016
Q1
Sell
-6,030
Closed -$610K 364
2015
Q4
$610K Sell
6,030
-2,570
-30% -$267K 0.28% 135
2015
Q3
$844K Buy
8,600
+4,280
+99% +$475K 0.47% 64
2015
Q2
$506K Sell
4,320
-1,290
-23% -$141K 0.28% 132
2015
Q1
$551K Buy
5,610
+1,220
+28% +$124K 0.31% 130
2014
Q4
$414K Buy
4,390
+990
+29% +$102K 0.25% 162
2014
Q3
$362K Hold
3,400
0.27% 148
2014
Q2
$282K Buy
+3,400
New +$265K 0.18% 196

Other funds holding GILD

Algert Global's GILD Position: Q1 2026 in Review

Algert Global sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 37,341 shares — an estimated $4.58M sold.

Algert Global first reported a position in GILD in Q2 2014 and held it in 15 quarters. The position peaked at $4.58M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Algert Global reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • Algert Global sold 37,341 Gilead Sciences shares in Q1 2026, an estimated $4.58M.
  • Algert Global first reported a position in Gilead Sciences in Q2 2014 and held it in 15 quarters.
  • Algert Global's Gilead Sciences position peaked at $4.58M in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.